US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 439.620
  • -0.110-0.03%
Close Jan 24 16:00 ET
  • 439.620
  • 0.0000.00%
Post 19:49 ET
113.22BMarket Cap-231.38P/E (TTM)

Vertex Pharmaceuticals Key Stats

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.798B--
--2024/Q4-- / 2.785B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.798B--
--2024/Q4-- / 2.785B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 24, 2025

Buy

  • Buy

    60.71%
  • Hold

    32.14%
  • Sell

    7.14%

Price Target

No Data